NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
Yahoo FinanceApr 24 07:07 ET
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%. The iShares Biotechnology ETF (IBB) dec
MT NewswiresApr 19 16:00 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersMobile-health Network (NASDAQ:MNDR) shares increased by 34.7% to $27.44 during Friday's regular session. The market value of their outstanding shares is at $932.9 million. NKGen Biotech (NASDAQ
BenzingaApr 19 12:31 ET
Predictive Oncology, BIMI Holdings, IMAC Holdings Among Healthcare Movers
Seeking AlphaApr 19 10:00 ET
NeuroMetrix Names New Independent Director, Terminates Equity Program; Shares up
Seeking AlphaApr 19 09:10 ET
NeuroMetrix Board Appointment and Equity Program Termination
TipRanksApr 19 08:22 ET
Express News | NeuroMetrix Appoints Joshua S. Horowitz As New Independent Director; Co. Also Terminates At-The-Market Equity Facility
Moomoo 24/7Apr 19 08:01 ET
Express News | NeuroMetrix Inc - Approved Appointment of Joshua S. Horowitz as a New Independent Director With a 1-Year Term
Moomoo 24/7Apr 19 08:00 ET
Express News | NeuroMetrix Inc - Terminated Its at--Market (Atm) Equity Facility It Had Entered Into With Ladenburg Thalmann & Co., Inc. on October 22, 2021.
Moomoo 24/7Apr 19 08:00 ET
Express News | NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
Moomoo 24/7Apr 19 08:00 ET
Press Release: NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value Joshua S. Horowitz joins Board of Directors At-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) --
Dow JonesApr 19 08:00 ET
Express News | NeuroMetrix Publishes Study Demonstrating That DPNCheck Diagnoses Diabetic Peripheral Neuropathy
Moomoo 24/7Mar 14 09:01 ET
NeuroMetrix Announces That Over 2000 Patients With Fibromyalgia Have Been Prescribed Quell Fibromyalgia
WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic co
GlobeNewswireMar 13 09:00 ET
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
Stock trades significantly below its net cash per share.The board is arguably in breach of their fiduciary responsibility to protect shareholder value. Operating any capital raise at current price is
AccesswireMar 8 12:15 ET
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
- Stock trades significantly below its net cash per share- Questions the Board's ability and/or desire to create shareholder value- Notes tremendous destruction of shareholder value under company's le
AccesswireMar 4 08:00 ET
MSTR, NNOX and CAN Are Among Pre Market Gainers
Seeking AlphaFeb 28 08:29 ET
NeuroMetrix Full Year 2023 Earnings: US$6.08 Loss per Share (Vs US$4.96 Loss in FY 2022)
Yahoo FinanceFeb 24 08:46 ET
Earnings Call Summary | NeuroMetrix(NURO.US) Q4 2023 Earnings Conference
The following is a summary of the NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript:Financial Performance:NeuroMetrix reported Q4 2023 revenue of $1.3 million, a decrease of 32% compared to th
moomoo AIFeb 22 12:23 ET · Conference Call
NeuroMetrix GAAP EPS of -$1.43, Revenue of $1.32B
Seeking AlphaFeb 22 07:09 ET
Express News | NeuroMetrix Q4 EPS $(1.43) Down From $(0.73) YoY, Sales $1.32M Down From $1.85M YoY
Moomoo 24/7Feb 22 07:02 ET
No Data
No Data